Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

TCS Ranked as the #1 Life Sciences Service Provider by HFS

Posted On: 2020-02-19 14:48:18


Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has been ranked #1 in the HFS Top 10 Life Sciences Service Providers Report[1].

The report highlights TCS' strong domain expertise across the life sciences value chain, as a key strength. It goes on to say that TCS' IP-led go-to-market approach that allows it to capture emerging opportunities in genomics, bio-informatics, connected devices, and 3-D printing by leveraging the TCS COIN ecosystem, was cited as a strength. The report also highlights TCS' Digital platforms for life sciences, including the award-winning TCS Advanced Drug Development (ADD) platform suite, the Decision FabricTM engine, TCS Connected Clinical TrialsTM and Cognitive Commercial Intelligence (CCI) Platform.

"Life sciences and healthcare companies are leveraging emerging technologies such as AI, IoT and blockchain to create a hyper-connected ecosystem and forging a path for patient-centric care," said Debashis Ghosh, Business Group Head, Life Sciences and Healthcare, TCS. "This #1 ranking by an independent third-party research firm is a strong validation of our ability to execute on a clear transformation vision for the life sciences industry, growth backed by innovation and continuous investments in platform solutions, and ability to consistently create business value for customers."

TCS works with leading life sciences companies to accelerate their business transformation journey by leveraging its Business 4.0TM framework and Machine First™ Delivery Model (MFDMTM). TCS offers a full set of IT and business process capabilities including regulatory services, predictive and prescriptive analytics, genomics research, advanced platform solutions for the entire clinical R&D value chain, medical device engineering, supply chain and manufacturing and sales and marketing. Early investments in re-skilling the workforce, building agile workplaces, and developing an extensive portfolio of intellectual property have helped TCS gain significant scale and depth across life sciences value chain.

TCS ADD is a suite of cloud-based platforms that leverage next-gen digital technologies such as automation, AI, and IoT to transform the entire clinical R&D value chain. TCS' CCI platform provides transformational and flexible analytics solutions to help the sales, marketing, pricing and market access functions within life sciences organizations make smarter decisions at scale. The TCS Real World Evidence platform provides end-to-end value evidence lifecycle management capabilities including real world data, knowledge and evidence management, study conduct and management, evidence generation and synthesis and value communication.

TCS' experts in the life sciences domain work closely with solution architects to come up with innovative solutions that use a combination of user-friendly digital platforms, clinical services KPO, AI, IoT/wearables, big data, 3-D printing, RPA, blockchain and cloud to achieve better speed to market and superior business outcomes.

"The role of third-party service providers in the life sciences industry is no longer just supporting 'business-as-usual', but to help enterprises drive 'meaningful change'. With investments in platforms such as the TCS - ADD Suite of platforms, TCS Connected Clinical Trials platform, and Cognitive Commercial Intelligence Platform, TCS brings to the table an IP-focused and platform-based offering set backed by strong domain expertise to do just that," said Saurabh Gupta, Chief Research Officer, HFS Research.

"Our ability to drive large scale digital transformation, continuous investments in intellectual property, and depth of digital talent and capabilities, position us as a preferred transformation partner for our customers in the life sciences industry," added Debashis Ghosh.

Shares of TATA CONSULTANCY SERVICES LTD. was last trading in BSE at Rs.2215.3 as compared to the previous close of Rs. 2203.25. The total number of shares traded during the day was 96139 in over 7748 trades.

The stock hit an intraday high of Rs. 2221.35 and intraday low of 2186.75. The net turnover during the day was Rs. 212176662.

1 HFS Top l0 Life Sciences Service Providers, Saurabh Gupta, Mayank Madhur, HFS Research, November 2019


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Castrol India Ltd appoints Mr. Udayan Sen as Nominee Director

RBL Bank allots 12580 shares

India Ratings Revises IndusInd Bank's Outlook to Negative; Affirms 'IND AA+'

Force Motors Ltd March 2020 sales drops 78.70% YoY

Moody's places IndusInd Bank's ratings under review for downgrade

DCB Bank announces revised Marginal Cost of Funds based Lending Rate

DCB Bank revises External Benchmark Linked Rate

CRISIL reaffirms ratings of Bhagwati Autocast Ltd

H.G. Infra Engineering Limited Supports India's Fight Against COVID-19

ICRA downgrades rating of PNB Housing Finance Limited's NCDs and Tier II bonds

Persistent Systems contributing Rs. 25 Crores ($3.3M) in support of COVID-19 efforts globally

CARE has reaffirmed issuer rating of Ashiana Housing Ltd

IDBI Bank updates on Moody's rating

CARE reaffirms rating of DCB Bank Limited

Sunteck Realty Limited's 'AA-' long-term and 'A1+' short-term ratings reaffirmed by CARE

PTC India Financial Services Ltd updates on credit ratings

Parsvnath Developers Ltd announces interest holiday to all its customers for 3 months

APM Terminals Pipavav offers Free Container Storage service at the port

NMDC revises iron ore price from April 4, 2020

Blue Dart ensures continuity of essential supply chain for the nation during COVID-19 outbreak

Nestlé India Extends Its Commitment To India's Fight Against COVID-19

Mr. Sunil D'Souza joins as Managing Director & CEO of Tata Consumer Products Ltd

TCPL Packaging Limited update on non-disposal undertaking by Promoter Group Companies

Moody's downgrades AXIS Bank outlook to Negative

HDFC Bank advances increases to Rs. 9,930 billion as of March 31, 2020

M&M Holds a Special Board Meeting to Review Investment in SsangYong Motor Company

Moody's affirms deposit ratings of ICICI Bank

GMR Infrastructure Limited updates on tariff order

Lasa pledge to contribute for fight against COVID 19

ICRA reaffirms ratings of HLE Glascoat Limited

Dhampur Sugar Mills Ltd starts hand sanitizers production at Asmoli unit

IEX assures the nation of 24X7 access to facilitate uninterrupted power supply

A kind initiative by UNO Minda group to fight against Corona

NMDC contributes Rs.60 Lakh to Ballari District Administration to support the fight against COVID-19

Ind-Ra revises long term issuer rating of HCL Infosystems Ltd

Oriental Aromatics Ltd starts partial production at Bareilly

Vedanta doubles its contribution to Rs. 201 crores to fight COVID-19

UPL contributes Rs. 75 Crore to PM-CARES Fund

IEX announces performance for March 2020

MOIL contributes Rs 45 crore in PM Cares Fund

KEI Industries Ltd. extends support to ISKCON Delhi to feed more than 2 lakh homeless daily

Ajanta Pharma commits Rs. 6 crore to fight COVID-19 pandemic

The Ramco Cements Ltd contributes Rs. 2.50 crores to Tamil Nadu CM Relief Fund

IDBI BANK LTD board to consider rupee bond borrowings limit for FY 2020-21

Raymond Ltd allots 18,54,599 shares

OnMobile Global Ltd board to consider buyback on Apr 9, 2020

National Fertilizers Ltd registers highest-ever Fertilizer sale in 2019-20

ITC Salutes its Frontline Warriors in the fight against Corona

Sportking India Ltd starts operations at Bathinda unit

Cyient to Partner with Hitachi Rail to Accelerate Signaling Technology Deployment







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019